Women's Health Issues
Volume 15, Issue 4 , Pages 187-195 , July 2005

After the women’s health initiative: Decision making and trust of women taking hormone therapy

Received 17 November 2004 ,Revised 12 January 2005 ,Accepted 28 March 2005.

References 

  1. Anderson RN , Smith BL . Death (leading causes for 2001) . National Vital Statistics Report . 2003;52(9):1–86
  2. Arnold DE , Holm RP . The quantity and quality of medical information available to the public . South Dakota Journal of Medicine . 1996;49(2):69–74
  3. Benbassat J , Pilpel D , Tidhar M . Patients’ preferences for participation in clinical decision-making (a review of published surveys) . Behavioral Medicine . 1998;24(2):81–88
  4. Blendon RJ , Taylor H . Views on health care (public opinion in three nations) . Health Affairs (Millwood) . 1989;8:149–157
  5. Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS, et al. Patients and clinicians’ attitudes after the women’s health initiative study . Menopause . 2004;11(1):57–61
  6. Boulware LE , Cooper LA , Ratner LE , Laveist TA , Powe NR . Race and trust in the health care system . Public Health Reports . 2003;118:358–365
  7. Breslau ES , Davis WW , Doner L , Eisner EJ , Goodman NR , Meissner HI , et al.   The hormone therapy dilemma (women respond) . Journal of the American Medical Women’s Association . 2003;58(1):33–43
  8. Brull R , Ghali WA , Quan H . Missed opportunities for prevention in general internal medicine . Canadian Medical Association Journal . 1999;160(8):1137–1140
  9. Burke W , Olsen AH , Pinsky LE , Reynolds SE , Press NA . Misleading presentation of breast cancer in popular magazines . Effective Clinical Practice . 2001;4(2):58–64
  10. Clinkingbeard C , Minton BA , Davis J , McDermott K . Women’s knowledge about menopause, hormone replacement therapy (HRT), and interactions with healthcare providers (an exploratory study) . Journal of Women’s Health and Gender Based Medicine . 1999;8(8):1097–1102
  11. Corbie-Smith G , Thomas SB , St. George DM . Distrust, race, and research . Archives of Internal Medicine . 2002;162:2458–2463
  12. Doescher MP , Saver BG , Franks P , Fiscella K . Racial and ethnic disparities in perceptions of physician style and trust . Archives of Family Medicine . 2000;9:1156–1161
  13. Ende J , Kazis L , Ash A , Moskowitz MA . Measuring patients’ desire for autonomy (decision making and information-seeking preferences among medical patients) . Journal of General Internal Medicine . 1989;4(4):360–361
  14. Ettinger B , Grady D , Tosteson AN , Pressman A , Macer JL . Effect of the Women’s Health Initiative on women’s decisions to discontinue postmenopausal hormone therapy . Obstetrics and Gynecology . 2003;102(6):1225–1232
  15. Glickman L , Hubbard M , Liveright T , Valciukas JA . Fall-off in reporting life events (effects of life change, desirability, and anticipation) . Behavioral Medicine . 1990;16(1):31–38
  16. Goodman E . (April 17) To swallow or not to swallow (that is the new vitamin question) . 1994; Boston Globe, A27.
  17. Green SM . Estrogens . In:  Green SM editors. Tarascon pocket pharmacopoeia . Loma Linda, CA: Tarascon Publishing; 2002;p. 82–86
  18. Haas JS , Kaplan CP , Gerstenberger EP , Kerlikowske K . Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results . Annals of Internal Medicine . 2004;140(3):184–189
  19. Hall MA , Camacho F , Dugan E , Balkrishnan R . Trust in the medical profession (conceptual and measurement issues) . HSR (Health Services Research) . 2002;37(5):1419–1439
  20. Hall MA , Dugan E , Zheng B , Mishra A . Trust in physicians and medical institutions (what is it, can it be measured, and does it matter?) . Milbank Quarterly . 2001;79(4):613–639
  21. Hersh AL , Stefanick ML , Stafford RS . National use of postmenopausal hormone therapy; annual trends and response to recent evidence . Journal of the American Medical Association . 2004;291(1):47–53
  22. Johnson BB , Slovic P . Presenting uncertainty in health risk assessment (initial studies of its effects on risk perception and trust) . Risk Analysis . 1995;15(4):485–494
  23. Lawton B , Rose S , McLeod D , Dowell A . Changes in use of hormone replacement therapy after the report from the Women’s Health Initiative (cross sectional survey of users) . British Medical Journal . 2003;327:845–846
  24. Marino C , Gerlach KK . An analysis of breast cancer coverage in selected women’s magazines, 1987–1995 . American Journal of Health Promotion . 1999;13(3):163–170
  25. Martin KA , Rosen HN , Barbieri RL . Hormone preparations for estrogen replacement therapy . 2003; Available: http://www.uptodateonline.com. Accessed April 22, 2003.
  26. Millon-Underwood S , Sanders E , Davis M . Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans . Cancer Nursing . 1993;16(1):25–33
  27. Mosca L , Jones WK , King KB , Ouyang P , Redberg RF , Hill MN . Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States . Archives of Family Medicine . 2000;9(6):506–515
  28. National Institutes of Health . NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit. July 9 . 2002; Available: http://www.nhlbi.nih.gov/new/press/02-07-09.htm/. Accessed January 23, 2005.
  29. Neuner JM , McCarthy EP , Davis RB , Phillips RS . Physician counseling on hormone replacement therapy and bone loss (do socioeconomic and racial characteristics of women influence counseling?) . Journal of Women’s Health . 2003;12(5):495–504
  30. North American Menopause Society . Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy . Menopause . 2003;10(1):6–12
  31. The Patient-Physician Relationship . The impact of managed care on patients’ trust in medical care and their physicians . JAMA . 1996;275(21):1693–1697
  32. Pearson SD , Raeke LH . Patients’ trust in physicians (many theories, few measures, and little data) . Journal of General Internal Medicine . 2000;15:509–513
  33. Pilote L . Attitudes of women toward hormone therapy and prevention of heart disease . American Heart Journal . 1995;129(6):1237–1238
  34. Roberson NL . Clinical trial participation. Viewpoints from racial/ethnic groups . Cancer . 1994;74(9 Suppl):2687–2691
  35. Rose A , Peters N , Shea JA , Armstrong K . Development and testing of the health care system distrust scale . Journal of General Internal Medicine . 2004;19(1):57–63
  36. Ruggiero RJ . Patient communication and counseling on contraception and hormone replacement therapy . American Journal of Managed Care . 2001;7(18 Supplement):S580–S585
  37. Safran DG , Taira DA , Rogers WH , Kosinski M , Ware JE , Tarlov AR . Linking primary care performance to outcomes of care . The Journal of Family Practice . 1998;47(3):213–220
  38. Saver BG , Taylor TR , Woods NF , Stevens NG . Physician policies on the use of preventive hormone therapy . American Journal of Preventive Medicine . 1997;13(5):358–365
  39. Schneider DL , Barrett-Connor EL , Morton DJ . Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo study . Journal of the American Medical Association . 1997;277(7):543–547
  40. Sleight P . Where are clinical trials going? Society and clinical trials . Journal of Internal Medicine . 2004;255:151–158
  41. U.S. Preventive Services Task Force . Postmenopausal hormone replacement therapy for primary prevention of chronic conditions (recommendations and rationale) . Annals of Internal Medicine . 2002;137:834–839
  42. Weng HH , McBride CM , Bosworth HB , Grambow SC , Siegler IC , Bastian LA . Racial differences in physician recommendation of hormone replacement therapy . Preventive Medicine . 2001;33:668–673
  43. Women’s Health Initiative Investigators . Estrogen plus progestin and the risk of coronary heart disease . New England Journal of Medicine . 2003;349(6):523–534
  44. The Women’s Health Initiative Steering Committee . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy (the Women’s Health Initiative randomized controlled trial) . Journal of the American Medical Association . 2004;291(14):1701–1712
  45. Writing Group . Cardiovascular disease in women (a statement for healthcare professionals from the American Heart Association) . Circulation . 1997;96:2468–2482
  46. Writing Group for the Women’s Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women; principal results from the Women’s Health Initiative randomized controlled trial . Journal of the American Medical Association . 2000;288(3):321–333
  47. Zhang J , Yu KF . What’s the relative risk? A method of correcting the odds ration in cohort studies of common outcomes . Journal of the American Medical Association . 1998;280(19):1690–1691

PII: S1049-3867(05)00023-X

doi: 10.1016/j.whi.2005.03.003

Women's Health Issues
Volume 15, Issue 4 , Pages 187-195 , July 2005

Article Tools

* Image Usage & Resolution